C3i appoints Yvan Côté as Chief Executive Officer, Paving the way for Strategic Growth and Innovation.

This fall has brought a new dynamic to C3i with the appointment of our new CEO, Yvan Côté. His expertise and leadership reinforce our commitment to elevating C3i to new heights.

With a background in biotechnology and cell biology, combined with his strong business development expertise, Yvan has played a pivotal role in the significant growth of every company he has worked with. After his tenure as CEO of Neopharm Labs, he had considered retirement, but the potential and ambition of C3i convinced him to take on a new challenge.

His goal: Make C3i a key player in the industry and contribute to saving lives.

At C3i, we share Yvan’s core values: innovation, collaboration, and excellence. He surrounds himself with leaders who bring complementary expertise, foster team empowerment and apply growth-driven management practices.

In the coming months, Yvan aims to increase revenue streams rapidly:

“C3i already has the expertise, the team, and the infrastructure to expand its service offering.”

To support this growth, he plans to hire an experienced sales leader to help drive this critical expansion phase.

A passionate hunter and fisherman, Yvan understands that patience, precision, and perfect timing are key to success. These qualities, combined with his expertise, will be invaluable assets in driving C3i forward.